S.I. No. 509/2025 - Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2025

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 31st October, 2025.

The Council of the Pharmaceutical Society of Ireland, in exercise of the powers conferred on the said Society by section 11 of the Pharmacy Act 2007 (No. 20 of 2007) (as adapted by the Health and Children (Alteration of Name of Department and Title of Minister) Order 2011 ( S.I. No. 219 of 2011 )), with the consent of the Minister for Health, hereby makes the following rules:

1. (1) These Rules may be cited as the Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2025.

(2) The Principal Rules, Rule 15 of the Rules of 2015, the Rules of 2017, the Rules of 2020, the Pharmaceutical Society of Ireland (Registration) (Amendment) (No. 2) Rules 2020 ( S.I. No. 563 of 2020 ), the Rules of 2023 and these Rules may be cited together as the Pharmaceutical Society of Ireland (Registration) Rules 2008 to 2025 and shall be construed together as one.

3. In these Rules—

“Principal Rules” means the Pharmaceutical Society of Ireland (Registration) Rules 2008 ( S.I. No. 494 of 2008 );

“Rules of 2015” means the Pharmaceutical Society of Ireland (Continuing Professional Development) Rules 2015 ( S.I. No. 553 of 2015 );

“Rules of 2017” means the Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2017 ( S.I. No. 100 of 2017 );

“Rules of 2020” means the Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2020 ( S.I. No. 316 of 2020 );

“Rules of 2023” means the Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2023 ( S.I. No. 452 of 2023 ).

4. Rule 3(1) (as amended by Rule 3 of the Rules of 2020) of the Principal Rules is amended, in the definition of “CPD Rules”, by inserting “, as amended by the Pharmaceutical Society of Ireland (Continuing Professional Development) (Amendment) Rules 2025 (S.I. No. XXX of 2025)” after “( S.I. No. 553 of 2015 )”.

5. Rule 11 (as amended by Rule 15(b) of the Rules of 2015) of the Principal Rules is amended by substituting for paragraph (8) the following paragraph:

“(8) Where an application for continued registration of a pharmacist does not contain, or is not accompanied by, the particulars referred to in paragraphs 7A and 7B of Schedule 2, Rule 12A shall apply to the application.”.

6. Rule 12 of the Principal Rules is amended by inserting after paragraph (3) the following paragraph:

“(3A) Where an application for continued registration of a pharmaceutical assistant does not contain, or is not accompanied by, the particulars referred to in paragraphs 7 and 8 of Schedule 3, Rule 12A shall apply to the application.”.

7. The Principal Rules are amended by inserting after Rule 12 the following Rule:

“Procedural provisions relating to failure to comply with CPD requirements

12A. (1) Where an application for continued registration of a pharmacist or pharmaceutical assistant comes within the circumstances referred to in Rule 11(8) or Rule 12(3A), the Council shall, unless there are extenuating circumstances giving rise to such circumstances as provided for in a Council approved policy, inform the applicant by written notice that it proposes to refuse the application.

(2) The notice referred to in paragraph (1) shall state—

(a) the proposal of the Council,

(b) the reasons on which the proposal is based, and

(c) that the applicant has the right to make representations to the Council in response to the proposal within a stated period of time not being less than 28 days from the date of the notice.

(3) A person to whom a notice referred to in paragraph (1) has been issued may, within the period of time referred to in paragraph (2)(c), send written representations to the Council in relation to the proposed refusal of the application for continued registration.

(4) The Council shall, after consideration of—

(a) any written representations sent to it pursuant to paragraph (3),

(b) any extenuating circumstances applying to the applicant,

(c) any CPD subsequently undertaken by the applicant, and

(d) such other matters as the Council considers appropriate,

decide whether to grant or refuse the application for continued registration.”.

8. Schedule 2 to the Principal Rules is amended by substituting for paragraph 7A (inserted by Rule 15(c) of the Rules of 2015) the following:

“7A. Confirmation of their engagement with the Institute of Pharmacy in relation to their obligations under the CPD Rules.”

9. Schedule 3 to the Principal Rules is amended by inserting after paragraph 6 the following paragraph:

“7. Confirmation of their engagement with the Institute of Pharmacy in relation to their obligations under the CPD Rules.”

I, Jennifer Carroll MacNeill, Minister for Health, consent to the making of the foregoing Rules.

GIVEN under the Official Seal of the Minister for Health,

23 October, 2025.

JENNIFER CARROLL MACNEILL,

Minister for Health.

GIVEN under my Official Seal,

23 October, 2025.

DENIS O’DRISCOLL,

President.

JOANNE KISSANE,

Registrar.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

These Rules amend the Pharmaceutical Society of Ireland (Registration) Rules 2008 to provide that failure to comply with continuing professional development requirements can lead to a refusal to continue the registration of a pharmacist in the Register of Pharmacists or pharmaceutical assistant in the Register of Pharmaceutical Assistants.

These Rules may be cited as the Pharmaceutical Society of Ireland (Registration) (Amendment) Rules 2025.